Search

Author/Creator Schwartz, Jonathan D.

1. A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Issue 11 (27th February 2014)

Authors:
Garcia, Jorge A.; Hudes, Gary R.; Choueiri, Toni K.; Stadler, Walter M.; Wood, Laura S.; Gurtler, Jayne; Bhatia, Shailender; Joshi, Adarsh; Hozak, Rebecca R.; Xu, Yihuan; Schwartz, Jonathan D.; Thompson, John A.
Journal:
Cancer
Issue:
Volume 120:Issue 11(2014)
Page Start:
1647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Issue 11 (27th February 2014)

Authors:
Garcia, Jorge A.; Hudes, Gary R.; Choueiri, Toni K.; Stadler, Walter M.; Wood, Laura S.; Gurtler, Jayne; Bhatia, Shailender; Joshi, Adarsh; Hozak, Rebecca R.; Xu, Yihuan; Schwartz, Jonathan D.; Thompson, John A.
Journal:
Cancer
Issue:
Volume 120:Issue 11(2014)
Page Start:
1647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer. Issue 13 (September 2015)

Authors:
Hussain, Maha; Rathkopf, Dana; Liu, Glenn; Armstrong, Andrew; Kelly, Wm. Kevin; Ferrari, Anna; Hainsworth, John; Joshi, Adarsh; Hozak, Rebecca R.; Yang, Ling; Schwartz, Jonathan D.; Higano, Celestia S.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 13(2015:Sep.)
Page Start:
1714
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An Open‐Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX‐6 as First‐Line Therapy for Metastatic Colorectal Cancer. (27th March 2014)

Authors:
Garcia‐Carbonero, Rocio; Rivera, Fernando; Maurel, Joan; Ayoub, Jean‐Pierre M.; Moore, Malcolm J.; Cervantes, Andres; Asmis, Timothy R.; Schwartz, Jonathan D.; Nasroulah, Federico; Ballal, Shaila; Tabernero, Josep
Journal:
Oncologist
Issue:
Volume 19:Number 4(2014)
Page Start:
350
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Minimal conditioning in Fanconi anemia promotes multi‐lineage marrow engraftment at 10‐fold lower cell doses. (1st October 2018)

Authors:
Haworth, Kevin G.; Ironside, Christina; Ramirez, Megan A.; Weitz, Sarah; Beard, Brian C.; Schwartz, Jonathan D.; Adair, Jennifer E.; Kiem, Hans‐Peter
Journal:
Journal of gene medicine
Issue:
Volume 20:Number 10/11(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients. Issue 8 (25th May 2021)

Authors:
Ramírez, María José; Pujol, Roser; Trujillo‐Quintero, Juan Pablo; Minguillón, Jordi; Bogliolo, Massimo; Río, Paula; Navarro, Susana; Casado, José A.; Badell, Isabel; Carrasco, Estela; Balmaña, Judith; Català, Albert; Sevilla, Julián; Beléndez, Cristina; Argilés, Bienvenida; López, Mónica; Díaz de...
Journal:
American journal of hematology
Issue:
Volume 96:Issue 8(2021)
Page Start:
989
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD. Issue 3 (24th January 2022)

Authors:
Schwartz, Jonathan D.; Barcellini, Wilma; Grace, Rachel F.; Bianchi, Paola; Zanella, Alberto; López Lorenzo, José Luis; Sevilla, Julián; Shah, Ami J.; Glader, Bertil; Nicoletti, Eileen; Navarro Ordoñez, Susana; Segovia, José Carlos
Journal:
American journal of hematology
Issue:
Volume 97:Issue 3(2022)
Page Start:
E120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗